Essential Hypotension and Allostasis Registry

Launched by CES UNIVERSITY · Dec 17, 2013

Keywords

ClinConnect Summary

The Essential Hypotension and Allostasis Registry is a research study aimed at understanding how blood pressure (BP) issues, such as low or high BP, can be influenced by stress and how these problems may lead to other health conditions. The study will observe patients of all ages and genders who visit a cardiologist in Medellin, Colombia. Researchers will categorize participants based on their BP levels and stress responses, tracking their health over time to learn more about how these factors contribute to various diseases, including conditions like depression, heart disease, and diabetes.

Anyone can join the study, as long as they do not have certain serious health issues that could affect the results, such as specific heart problems or autoimmune diseases. Participants can expect to have their BP monitored and to share information about their stress levels during the study. This research could help improve our understanding of how stress impacts health and inform better treatment strategies in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient regardless of the age of gender
• Exclusion Criteria:
• • Any non-correctable secondary cause of increase or decrease in blood pressure
• • or a pathology that alters the prognosis before the entrance of the patient into this registry.
• • nephropathy prior to the admission,
• • familial dyslipidemia,
• • previous gastric bypass,
• • pre-existing heart failure,
• • chemotherapy-induced cardiotoxicity,
• • arrhythmogenic right ventricular dysplasia,
• • long QT syndrome,
• • hypertrophic cardiomyopathy
• • restrictive cardiomyopathy or sudden death syndromes other than coronary disease
• • Down syndrome,
• • having one single kidney before entering to this registry,
• • polycystic kidney,
• • disability to continue with the treatment
• • organ transplantation (other than cornea),
• • HIV positive,
• • homocystinuria,
• • myelomeningocele,
• • autoimmune diseases,
• • paraplegia,
• • chronic infections (TB),
• • myocarditis of any cause,
• • blood dyscrasia with coagulation disorders,
• • history of pulmonary embolism,
• • sustained or non-sustained ventricular tachycardia,
• • idiopathic tachycardia associated with syncope which is not cured by radiofrequency ablation,
• • pulmonary hypertension,
• • diabetes insipidus,
• • COPD,
• • Gitelman syndrome,
• • Cervical cancer associated with human Papillomavirus,
• • multiple sclerosis,
• • hemochromatosis,
• • not compact ventricle.
• • It is important to emphasize that all of these patients, currently excluded from the registry, may be studied in the future, they keep on follow-up and taken 6 BP.
• • Additionally it is planned to compare the evolution of patients with secondary causes of hypertension or hypotension with essential disorders